Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Neuroscience ; 322: 408-15, 2016 May 13.
Article in English | MEDLINE | ID: mdl-26946266

ABSTRACT

Dexras1 is a novel GTPase that acts at a confluence of signaling mechanisms associated with psychiatric and neurological disease including NMDA receptors, NOS1AP and nNOS. Recent work has shown that Dexras1 mediates iron trafficking and NMDA-dependent neurodegeneration but a role for Dexras1 in normal brain function or psychiatric disease has not been studied. To test for such a role, mice with germline knockout (KO) of Dexras1 were assayed for behavioral abnormalities as well as changes in NMDA receptor subunit protein expression. Because Dexras1 is up-regulated during stress or by dexamethasone treatment, we included measures associated with emotion including anxiety and depression. Baseline anxiety-like measures (open field and zero maze) were not altered, nor were depression-like behavior (tail suspension). Measures of memory function yielded mixed results, with no changes in episodic memory (novel object recognition) but a significant decrement on working memory (T-maze). Alternatively, there was an increase in pre-pulse inhibition (PPI), without concomitant changes in either startle amplitude or locomotor activity. PPI data are consistent with the direction of change seen following exposure to dopamine D2 antagonists. An examination of NMDA subunit expression levels revealed an increased expression of the NR2A subunit, contrary to previous studies demonstrating down-regulation of the receptor following antipsychotic exposure (Schmitt et al., 2003) and up-regulation after exposure to isolation rearing (Turnock-Jones et al., 2009). These findings suggest a potential role for Dexras1 in modulating a selective subset of psychiatric symptoms, possibly via its interaction with NMDARs and/or other disease-related binding-partners. Furthermore, data suggest that modulating Dexras1 activity has contrasting effects on emotional, sensory and cognitive domains.


Subject(s)
Anxiety Disorders/metabolism , Memory, Short-Term/physiology , Prepulse Inhibition/physiology , Receptors, N-Methyl-D-Aspartate/metabolism , ras Proteins/metabolism , Animals , Maze Learning/physiology , Memory, Episodic , Mice, Inbred C57BL , Mice, Knockout , Motor Activity/physiology , Recognition, Psychology/physiology , ras Proteins/genetics
2.
Talanta ; 50(6): 1275-81, 2000 Jan 10.
Article in English | MEDLINE | ID: mdl-18967824

ABSTRACT

The electrogenerated chemiluminescent (ECL) behavior of hemin at a platinum electrode in the alkaline solution has been investigated in detail. Under the optimum conditions the linear response range of hemin is 1.0 x 10(-5)-1.0 x 10(-8) g ml(-1), the detection limit was 1.0 x 10(-8) g ml(-1), and the relative standard derivation for 1 x 10(-7) g ml(-1) hemin was 2.8%. It has been also found that hemin would catalyze the ECL of lucigenin at a platinum electrode in a neutral solution in the presence of hydrogen peroxide, the catalytic ECL intensity was linear with the concentration of hemin in the range of 1.0 x 10(-14)-1.0 x 10(-10) g ml(-1). IgG labeled with hemin was used to examine the ECL catalytic activity of hemin after conjugating to protein, and the results showed that hemin retained ECL catalytic activity when conjugated to protein.

SELECTION OF CITATIONS
SEARCH DETAIL
...